DEADLINE UPDATED: 31 July 2020 – Expressions of interest sought for president of the Renal Association

  • As a result of the current situation the deadline for this position has been updated to the 31 July 2020. 

The president of the Renal Association (RA) is responsible for the strategic direction of the association and is the external face, ensuring effective working relations with external bodies whose work is relevant to the interests of the RA. The position is a substantial task in light of the rapidly evolving clinical, training and academic environment. However, in the current challenging NHS environment it remains an important influential and highly rewarding role.

The full role description can be viewed here.

Term of office
The role is appointed for a maximum term of office of five years in total which shall comprise of: one year as president-elect, followed by two years as president (which may be extended by one additional year with the agreement of a majority of trustees), followed by two years as immediate past president (which shall be reduced to one year in the event that the two year term as president is extended by one additional year); following which she or he shall not serve again in this office. The president-elect will be a trustee of the RA from June 2020.

Appointment process

  • The role is open to any member of the RA in good standing
  • Please then complete a nomination form including the names of a proposer and seconder, both of whom must be members of the RA (but not trustees), accompanied by your CV and a brief statement of intent (maximum of 500 words) describing your plans if elected and return to renal@renal.org by 9:00 31 July 2020.
  • The role is elected following a ballot of the membership, the person gaining the majority of votes is appointed. The outcome of the election will be announced in early May.

Potential candidates are recommended to take a realistic review of their own work programme before being nominated and to seek the support of their colleagues and employing organisation. The president receives no remuneration from the RA; but will be reimbursed for necessary travel expenses. In recognition of the workload of this role the RA has submitted an application to the Charity Commission to amend its articles in order to compensate the president’s NHS trust for one programmed activity session per week. This has not yet been reviewed by the Charity Commission is in no way guaranteed.

Those considering nomination are strongly encouraged to discuss the role with the President, Graham Lipkin, another trustee of the association or the Chief Executive, Ron Cullen.

The Renal Association is committed to creating and sustaining a positive, fair and mutually supportive environment. We accept, respect and value people with diverse identities and backgrounds and believe our differences make us stronger and more effective in achieving our goals. We encourage applications from all suitably qualified and eligible candidates and are committed to facilitating options such as job share. If you would like to submit your nomination as a job share, or would like to explore a novel approach to delivering this role, please mention this in your statement of intent.

Dr Graham Lipkin, Renal Association President says:

“ It has been a genuine real privilege and great fun to be President of this great association which incorporates the sterling work of the Renal Registry and professional arms, now half way through my term of office. The position is strongly supported by fellow trustees, a dynamic CEO and expanding executive and a highly effective secretariat.

The generosity in time and effort of my fellow trustees and council members has made my time a real pleasure, with a true sense of shared goals. The renal community is indeed special, steeped in a proud history of innovation and delivery. We are a small speciality but with big ambitions and major achievements both in the past and looking forward. The RA has never been in such a strong position to meet its mission and charitable objects. We have a strong bed rock of governance and solid finances with record membership, a corporate strategy that is delivering and strong income from highly acclaimed annual conference. There is an ambitious three year strategy agreed and almost all committees are delivering well. The opportunities ahead to lead the whole community and bring in more members to fulfil the strategy have never been so great. The possibilities to support and enable research through the registry are enormous. The opportunities of joint working with the BRS and affiliates are transformational as is the opportunity to develop our rare disease strategy.

Whilst very rewarding, there is a significant time commitment to the role. These days it is more difficult to organise time within our NHS roles and we hope that the position will come with one paid session to enable. This will hopefully be agreed at our AGM in June. I wish my successor every success and my support in my year as past president starting June 2021.”